Listeria has been in the headlines a lot this year. In 2016, Listeria outbreaks have affected several major brands and have been linked to at least three deaths.
Recent Posts
Pharmaceutical sales reps spend much of their time on the road driving from office to office and hospital to hospital. Besides a boatload of swag, they are carrying various drug samples with them.
What happens when those samples are temperature sensitive and require refrigeration?
Clinical trials are the lifeblood of the pharmaceutical industry. Without successful new drug development, brands would become commoditized as patents expire and low-cost generics enter the market.
The CDC recommends that medications be kept within specific refrigerated and frozen temperature ranges to ensure safety and efficacy (Vaccine Storage and Handling Toolkit).
Drug manufacturers are well aware of these recommendations and take precautions to properly store their medications. However, there is a link in the Cold Chain that is often overlooked. We refer to that missing link as the “Forgotten Mile.”
In our last post, we gave an overview of track and trace. This legislation is a critical step to improving the safety and efficacy of prescription drugs in the U.S. However, it alone may not be sufficient for all medications. In addition to trace and trace, manufacturer’s will need to consider cold chain custody tracking of temperature sensitive medications such as vaccines or insulin.
Pharmaceutical track and trace legislation has arrived. Signed in 2013, Title II of the Drug Quality and Security Act outlines specific steps to build an electronic system to track and trace prescription drugs in the U.S.
